The most commonly used GLP-1 medication is semaglutide, which is marketed as Ozempic, Wegovy. These drugs, initially designed for managing type 2 diabetes, are now showing remarkable results in ...
Zealand's weight management product candidates include Survodutide (licensed by Boehringer), Petrelintide and Dapiglutide (see image below). However, given the developmental stage of the products ...
In February 2007, the FDA updated guidance to industry regarding the development of products for weight management. Key efficacy and safety recommendations were as follows [104]: "...weight loss ...